Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ATP6 pseudogene 29 (MTATP6P29) is annotated as a pseudogene in the human genome. Pseudogenes are non-functional sequences that resemble functional genes but typically lack the ability to encode proteins due to mutations or truncations. MTATP6P29 is related to the functional MT-ATP6 gene (which encodes an essential subunit of mitochondrial ATP synthase involved in cellular energy production), but MTATP6P29 itself does not produce functional protein[4]. It is not known to have any biological function or role in human disease, is not considered a therapeutic target, and has no known drug interactions. MTATP6P29 is not a protein, receptor, transporter, nor an active enzyme; it is a pseudogene[4]. It does not have known therapeutic, biomarker, or safety relevance in humans. There is no evidence for any role in disease or drug mechanism. This entry appears to be due to either database artifact or confusion with the functional MT-ATP6 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ATP6 pseudogene 29 (MTATP6P29).